Skip Navigation

This Article
Right arrow Full Text (PDF )
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (46)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Heikinheimo, O.
Right arrow Articles by Laähteenmaäki, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heikinheimo, O.
Right arrow Articles by Laähteenmaäki, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 2, No. 5, pp. 379-385, 1987
© 1987 European Society of Human Reproduction and Embryology

research-article

Metabolism and serum binding of Ru 486 in women after various single doses*

O. Heikinheimo1, P. L. A. Laähteenmaäki,, E. Koivunen2, D. Shoupe3, H. Croxatto4, T. Luukkainen and P. Laähteenmaäki

Steroid Research Laboratory, Department of Medical Chemistry 2Department of Obstetrics and Gynecology, University of Helsinki Siltavuorenpneger 10A, SF-00170 Helsinki, Finland 3Departments of Obstertics abd Gynecology, Section of Reproductive Endocrinology, University of Southern California Los Angeles, CA USA 4Instituto Chileno De Medicina Reproductiva, Santiago, Chile

Correspondence: 1To whom correspondence should be addressed

The metabolism of RU 486 was studied in female volunteers following a single oral administration of 100, 400, 600 or 800 ing of RU 486. The serum concentrations of RU 486 were generally not affected by the dose within the range examined and they stayed at micromolar concentrations during the 48 h studied. RU 486 was metabolized extensively in a dose-dependent manner by two-step demethylation, and by hydroxyl-ation. Serum levels of the monodemethylated metabolite always exceeded those of RU 486. The concentrations of the didemethylated and hydroxylated metabolites equalled or exceeded those of RU 486 when the ingested dose was 400 mg or more. Monodemethylation and hydroxylation were rapid high-capacity reactions, whereas didemethylation was a tower-capacity reaction. In each group of different dosage, positive correlations were found between the individual mean {alpha} 1-acid glycoprotein (AAG) concentrations and the peak concentration of RU 486 measured at 1-2 h, versus the plateau concentration of RU 486 measured at 6 h. The in-vitro studies showed that the specific serum transport protein of RU 486, AAG, was saturated by RU 486 concentrations exceeding 2.5 /tM. In serum at 40 nM and 2.5 /tM RU 486 concentrations, 2.7% and 2.4%, respectively, of [3H]RU 486 was not protein bound. Purified AAG in phosphate buffer was able to bind [3H]RU 486 in a similar manner to that of serum. Thus our results suggest that AAG regulates in part the serum concentrations of RU 486, and RU 486 exceeding the specific serum transport capacity is effectively metabolized.

Key words: {alpha}1-acid glycoprotein/antiprogesterone RU 486


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
A. A. Goyeneche, R. W. Caron, and C. M. Telleria
Mifepristone Inhibits Ovarian Cancer Cell Growth In vitro and In vivo
Clin. Cancer Res., June 1, 2007; 13(11): 3370 - 3379.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
S. Lalitkumar, M. Bygdeman, and K. Gemzell-Danielsson
Mid-trimester induced abortion: a review
Hum. Reprod. Update, January 1, 2007; 13(1): 37 - 52.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
O. Heikinheimo, T. Raivio, H. Honkanen, S. Ranta, and O. A. Janne
Termination of Pregnancy with Mifepristone and Prostaglandin Suppresses Transiently Circulating Glucocorticoid Bioactivity
J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 323 - 326.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
J.M. Larner, J.R. Reel, and R.P. Blye
Circulating concentrations of the antiprogestins CDB-2914 and mifepristone in the female rhesus monkey following various routes of administration
Hum. Reprod., May 1, 2000; 15(5): 1100 - 1106.
[Abstract] [Full Text] [PDF]

Home page
 Arch Fam MedHome page
B. D. Weiss
RU 486: The Progesterone Antagonist
Arch Fam Med, January 1, 1993; 2(1): 63 - 69.
[Abstract] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.